APA

von Moos R., Seifert B., Simcock M., Goldinger S. M., Gillessen S., Ochsenbein A., Michielin O., Cathomas R., Schläppi M., Moch H., Schraml P. H., Mjhic-Probst D., Mamot C., Schönewolf N. & Dummer R. (20120522). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

von Moos R, Seifert B, Simcock M, Goldinger S M, Gillessen S, Ochsenbein A, Michielin O, Cathomas R, Schläppi M, Moch H, Schraml P H, Mjhic-Probst D, Mamot C, Schönewolf N and Dummer R. 20120522. First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

von Moos R., Seifert B., Simcock M., Goldinger S. M., Gillessen S., Ochsenbein A., Michielin O., Cathomas R., Schläppi M., Moch H., Schraml P. H., Mjhic-Probst D., Mamot C., Schönewolf N. and Dummer R. (20120522). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

von Moos R, Seifert B, Simcock M, Goldinger S M, Gillessen S, Ochsenbein A, Michielin O, Cathomas R, Schläppi M, Moch H, Schraml P H, Mjhic-Probst D, Mamot C, Schönewolf N and Dummer R. First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). : Annals of oncology : official journal of the European Society for Medical Oncology. 20120522.